ANBLB1: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Neuroblastoma Biology Studies

Categories:

Tissue Bank

Supportive Solid Tumor Studies

Diseases Treated:

Neuroblastoma

Eligibility Overview:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

  • All newly diagnosed suspected:
    • neuroblastoma,
    • ganglioneuroblastoma, or 
    • ganglioneuroma (maturing subtype) patients
  • Less than or equal to 21 years of age
  • Seen at Children's Oncology Group (COG) institutions

Description

Neuroblastoma is the most common extra-cranial solid tumor in children. It arises from immature nerve cells in the abdomen, chest, or neck of young children. There are many different “kinds” of neuroblastoma tumors. Researchers have learned a lot about the characteristics of neuroblastoma tumors. Researchers believe there is more helpful information that can be gathered by further study of neuroblastoma tumors. This information can be used to develop better treatments for neuroblastoma and to further improve ways of predicting how the disease will respond to treatment. During this study, researchers will confirm the diagnosis of neuroblastoma in each subject and will help decide the best treatment for each subject. Researchers will also conduct special tests on tissue samples from neuroblastoma tumors.

Objectives

  • To confirm the diagnosis of neuroblastoma, as well as to help decide the best treatment.
  • To do research tests on neuroblastoma tissue.
  • To store leftover tumor tissue, genetic material, and blood samples for future research.

Eligibility

  • All newly diagnosed suspected:
    • neuroblastoma,
    • ganglioneuroblastoma, or
    • ganglioneuroma (maturing subtype) patients
  • Less than or equal to 21 years of age
  • Seen at Children's Oncology Group (COG) institutions
  • Certain specimens are required. Please contact St. Jude Children's Research Hospital for more information.    

Only current St. Jude patients are eligible for non-therapeutic studies, including this one.

Principal Investigator

Sara Federico, MD

St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105  USA
Voice: 1-888-226-4343 or 901-595-4055
24-Hour Emergency Access Pager: 1-800-349-4334

Referring or consulting clinicians only: protocolinfo@stjude.org
For all other inquiries about St. Jude Children's Research Hospital studies: referralinfo@stjude.org

The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.